Pharmaceutical Technology
OCTOBER 28, 2022
It aims to ensure the quality of medicines by employing statistical, analytical, and risk-management methodology in the design, development, and manufacturing processes of medicines. There are many variabilities with biosimilars and the brand name protein drug.”
Pharmaceutical Technology
APRIL 4, 2023
The southern states Andhra Pradesh and Telangana house almost a quarter of India’s contract manufacturing facilities; their sites supplying medicines to the US and EU have grown robustly over the last four years. US reliance on India for generic drugs could have supply chain security and quality implications for critical medicines.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
MARCH 21, 2023
The work promises to reduce the threats of viral contamination when harnessing bacteria to produce medicines such as insulin as well as other useful substances, such as biofuels. coli to make all their life-sustaining proteins from 61 sets of genetic building blocks, or codons, instead of the naturally occurring 64.
Roots Analysis
OCTOBER 24, 2023
Owing to the advancement in clinical pharmacology and oncology domain, and the rising demand for targeted therapeutics and precision medicines, high potency active pharmaceutical ingredients (HPAPIs) and cytotoxic drugs have become one of the key areas of interest to researchers and drug manufacturers across the globe.
Pharmaceutical Technology
JULY 22, 2022
Peter Hotez, a vaccine scientist and professor and dean at the National School of Tropical Medicine at the Baylor College of Medicine (BCM), shared an article on the Seattle biotech company, PAI Life Sciences having launched a trial for the tropical disease schistosomiasis.
pharmaphorum
JULY 21, 2022
If businesses have received a notice of inspection, they should focus on two key things: Adulteration: proof there is no chemical, microbial, viral, or other type of contamination in products. in structural characterization of medicinal products and an MBA in management. However, we understand that this is not always possible.
Camargo
NOVEMBER 29, 2021
The development of biological products (or biologics) represents a major advancement in modern medicine, enabling the treatment of patients with many illnesses where no other therapeutics were previously available. Recombinant therapeutic proteins. Fusion proteins. Gene and cellular therapies. Growth factors. Interferons.
Expert insights. Personalized for you.
130 
Let's personalize your content